Genesis Drug Discovery 2018

Published on 23/04/2018

10 – 11 May, 2018

Barcelona, Spain

“Genesis Drug Discovery (GDD) brings the most innovative event that aims to provide an open and stimulating scientific and cultural exchange that will give all the participants the opportunity to share their experiences, foster collaborations across industry and academia and evaluate emerging technologies across the globe.

Genesis Drug Discovery (GDD) provides a platform to promote international exchanges for drug discovery, and to accelerate the cooperation for new drug research and development in the global market. The Summit feature talks on the cutting edge of the discipline that include new compounds, targets, drug design, synthesis methods and technologies that advance the science from leaders in the pharmaceutical, biotech and academic spaces. Genesis Drug Discovery (GDD) will be attracting senior strategic decision-makers with top-level speakers, interactive round-tables, knowledge-sharing panel sessions, in-depth workshops and superb networking.”

https://pgsolx.com/Genesis/GDD/2018/

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US